Open mobile menu
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
Microchip
Industry news, News 01/05/2021

Standard Essential Patents and FRAND Licences

AI
Events 30/04/2021

IP Law Europe Summit May 2021 - Online

Ireland UPC
News 27/04/2021

Former Accenture patent attorney to head new Secerna Dublin office

Lego
European, Industry news, News 30/03/2021

T‑515/19 LEGO Decision

Syringe 2021
News 27/03/2021

Intellectual Property and Equitable Access to COVID-19 Technologies

EPO
News 16/03/2021

G 1/19 Decision

JP3 2931 (1)
News, Team news 10/03/2021

Secerna attracts top new talent as growth curve continues

Ear Of Wheat
European, Industry news, News 03/03/2021

Plant Variety Rights “post-Brexit”

JP3 1267
Team news, Careers 23/02/2021

Daniel Pingstone in profile

24 25 26 27 28 29 30 31 32 33 34